Online doctor-booking platform Meddy has raised a whopping $2.5 million in its latest Series A round. The proceeds from the round will be used to scale up the company’s operations in the UAE.
The round was led by Modus Capital, a US-based venture capital fund, with significant contributions coming from 212 Capital, Kasamar Holdings, Innoway, and Dharmendra Ghai, among others.
Launched in 2016, Meddy inaugurated operations in Dubai and Sharjah in 2018. If all goes well, the startup may launch new units in Abu Dhabi and other surrounding emirates in the foreseeable future.
For those unfamiliar with the brand, Meddy is a consumer-facing startup that helps patients find the best doctors anywhere in the country and book appointments with them. The platform lists a wide range of doctors that users can select based on their needs, locations, and other preferences.
To help ease the process, Meddy allows user-reviews of all doctors on the platform so patients can learn from the experiences of their peers and make an informed choice.
Additionally, Meddy also offers a comprehensive site of products to clinics so they can efficiently manage bookings and marketing/operational analytics. This feature is aimed at helping clinics improve their online visibility while simultaneously empowering them to attract new patients.
Meddy claims to have helped medical practitioners across the GCC by helping them attract new patients.
Explaining the decision to back Meddy, Kareem Elsirafy, a partner at Modus Capital, said: “We see Meddy as the up and coming leader in providing booking services to clinics in the GCC. Haris and the team have proven they clearly understand the needs of their customers, and the positive feedback and value-added they provide have created a very strong foundation for rapid regional growth. We’re excited to have Meddy in our portfolio and look forward to supporting them in their continued growth.”
Haris Aghadi, CEO at Meddy, said “In the last 6 months, we have more than doubled our bookings and provider network in the UAE. We are excited to have more fuel to keep working on our mission to help patients make informed health decisions.”
